Home › Trial NCT04947241
Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC
- Trial IDNCT04947241
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorFifth Affiliated Hospital, Sun Yat-Sen University
- Enrollment20
- Start date2020-12-15
- ConditionsLocally Advanced Head and Neck Squamous Cell Carcinoma · Neoadjuvant Therapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.